The Chemours Company
CC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,379,781 | $1,720,233 | $2,028,391 | $2,532,059 |
| - Cash | $613,000 | $502,000 | $464,000 | $713,000 |
| + Debt | $255,000 | $4,407,000 | $4,381,000 | $4,355,000 |
| Enterprise Value | $2,021,781 | $5,625,233 | $5,945,391 | $6,174,059 |
| Revenue | $1,495,000 | $1,615,000 | $1,368,000 | $1,394,000 |
| % Growth | -7.4% | 18.1% | -1.9% | – |
| Gross Profit | $235,000 | $278,000 | $236,000 | $273,000 |
| % Margin | 15.7% | 17.2% | 17.3% | 19.6% |
| EBITDA | $198,000 | $152,000 | $154,000 | $154,000 |
| % Margin | 13.2% | 9.4% | 11.3% | 11% |
| Net Income | $60,000 | -$381,000 | -$4,000 | -$8,000 |
| % Margin | 4% | -23.6% | -0.3% | -0.6% |
| EPS Diluted | 0.399 | -2.54 | -0.027 | -0.053 |
| % Growth | 115.7% | -9,413.1% | 50% | – |
| Operating Cash Flow | $146,000 | $93,000 | -$112,000 | $138,000 |
| Capital Expenditures | -$41,000 | -$43,000 | -$84,000 | -$109,000 |
| Free Cash Flow | $105,000 | $50,000 | -$196,000 | $29,000 |